ARAY-Accuray Stock Research, Ratings, and Analysis

Accuray (aray) Stock Research

Last Updated by Anonymous | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics aray SWOT Analysis

Strengths + Opportunities = 3

Threats + Weaknesses = 0

Add your knowledge to the Accuray SWOT analysis.

Generic Strategy aray Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Accuray does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: Accuray Incorporated, incorporated in 1990, designs and develops the CyberKnife system. The CyberKnife system is an image-guided robotic radio surgery system for the treatment of solid tumors, delivering high doses of radiation to a tumor from different directions. It tracks, detects, and corrects for tumor and patient movement in real-time during the treatment. Based in Sunnyvale, California, Accuray markets the CyberKnife system in the United States and internationally. Update

Market Research Update

Health Care Industry Research & Analysis: The health care industry depends on the care of health-related services by professionals for the benefit of patients. Medical device markers, insurance companies, pharmaceutical drug developers and government institutions are major participants in the treatment of sick, injured and disabled patients. Health Care Trading Strategy: Health Care stocks tend to be less sensitive to economic changes. Look for undervalued health care investments at any point in the business cycle when stock prices are low. However, biotech, employment staffing and insurance companies may all decrease during recessions for different reasons. Government intervention is another important factor in health care investments, since government spending in health care is a very large portion of overall health care spending. When governments change spending plans, different sub-sectors in the industry are significantly affected. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: . Accuray is a dominant industry leader due to its personnel, experience and financial strengths. Industry leaders are difficult to compete against, which decreases business and investor risks.

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Strategy: Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: